{
    "clinical_study": {
        "@rank": "144625", 
        "acronym": "ACCURATE", 
        "arm_group": [
            {
                "arm_group_label": "AXIUM Neurostimulator System", 
                "arm_group_type": "Experimental", 
                "description": "The AXIUM Neurostimulator System is an investigational spinal cord stimulation device that is designed to stimulate the dorsal root ganglion (DRG) of the spine located on the back surface of the spinal cord where nerves exit the backbone.  The device has 2 parts that are placed surgically (implanted) : 1) a pulse generator which is placed under the skin in the buttocks or abdomen, and 2) up to four wires (leads) that have one end attached to the pulse generator, and the other end secured to the tissue near the target treatment area."
            }, 
            {
                "arm_group_label": "Control Spinal Cord Stimulation Device", 
                "arm_group_type": "Active Comparator", 
                "description": "The Control Spinal Cord Stimulation Device is a commercially available spinal cord stimulator indicated for the treatment of chronic lower limb pain."
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to evaluate the safety and effectiveness of the AXIUM\n      Neurostimulator System for the treatment of chronic lower limb pain in persons diagnosed\n      with Complex Regional Pain Syndrome (CRPS) or Peripheral Causalgia (PC)."
        }, 
        "brief_title": "A Safety and Effectiveness Trial of Spinal Cord Stimulation of the Dorsal Root Ganglion for Chronic Lower Limb Pain", 
        "completion_date": {
            "#text": "December 2018", 
            "@type": "Anticipated"
        }, 
        "condition": "Chronic Lower Limb Pain", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Subject is male or female between the ages of 22 and 75 years\n\n          2. Subject is able and willing to comply with the follow-up schedule and protocol\n\n          3. Subject has chronic, intractable pain of the lower limb(s) for at least 6 months\n\n          4. Subjects are diagnosed with complex regional pain syndrome (CRPS) and/or peripheral\n             causalgia\n\n          5. Subjects have a minimum VAS greater than or equal to 60 mm in the area of greatest\n             pain in the lower limbs.\n\n          6. Subject has failed to achieve adequate pain relief from at least 2 prior\n             pharmacologic treatments from at least 2 different drugs classes\n\n          7. Subject has had stable neurologic function in the past 30 days\n\n          8. In the opinion of the Investigator, the subject is psychologically appropriate for\n             the implantation of an active implantable medical device\n\n          9. Subject is able to provide written informed consent\n\n        Exclusion Criteria:\n\n          1. Back pain is the greatest region of pain as measured on the baseline VAS.\n\n          2. Female subject of childbearing potential is pregnant/nursing, plans to become\n             pregnant or is unwilling to use approved birth control\n\n          3. Subject has exhibited escalating or changing pain condition within the past 30 days\n             as evidenced by Investigator examination\n\n          4. Subject is currently involved in medically related litigation, including workers\n             compensation\n\n          5. Subject has had corticosteroid therapy at an intended site of stimulation within the\n             past 30 days\n\n          6. Subject's pain medication(s) dosage(s) are not stable for at least 30 days\n\n          7. Subject has had radiofrequency treatment of an intended target DRG within the past 3\n             months\n\n          8. Subject has previously failed spinal cord stimulation therapy\n\n          9. Subject currently has an active implantable device including ICD, pacemaker, spinal\n             cord stimulator or intrathecal drug pump or subject requires magnetic resonance\n             imaging (MRIs) or diathermy\n\n         10. Subject has pain only within a cervical distribution\n\n         11. Subject has cognitive, physical or sensory impairment that, in the opinion of the\n             Investigator, may limit their ability  to operate the device\n\n         12. Subject currently has an indwelling device that may pose an increased risk of\n             infection\n\n         13. Subject currently has an active systemic infection.\n\n         14. Subject has, in the opinion of the investigator, a medical comorbidity that\n             contraindicates placement of an active medical device\n\n         15. Subject has participated in another clinical investigation within 30 days\n\n         16. Subject has a coagulation disorder or uses anticoagulants that, in the opinion of the\n             Investigator, precludes participation\n\n         17. Subject has been diagnosed with cancer in the past 2 years\n\n         18. Imaging (MRI, CT, x-ray) findings within the last 12 months that, in the\n             Investigator's opinion, contraindicates lead placement\n\n         19. Subject is a prisoner"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "75 Years", 
            "minimum_age": "22 Years"
        }, 
        "enrollment": {
            "#text": "152", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "August 13, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01923285", 
            "org_study_id": "03-SMI-2012"
        }, 
        "intervention": [
            {
                "arm_group_label": "AXIUM Neurostimulator System", 
                "intervention_name": "AXIUM Neurostimulator System", 
                "intervention_type": "Device", 
                "other_name": "DRG Stimulation"
            }, 
            {
                "arm_group_label": "Control Spinal Cord Stimulation Device", 
                "intervention_name": "Control Spinal Cord Stimulation Device", 
                "intervention_type": "Device", 
                "other_name": "SCS"
            }
        ], 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "October 25, 2013", 
        "link": {
            "description": "Click here for more information about this study: ACCURATE Trial", 
            "url": "http://www.accuratestudy.com"
        }, 
        "location": [
            {
                "contact": {
                    "last_name": "Renee Bell", 
                    "phone": "707-252-9606"
                }, 
                "facility": {
                    "address": {
                        "city": "Napa", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "94558"
                    }, 
                    "name": "Neurovations, Inc."
                }, 
                "investigator": {
                    "last_name": "Eric Grigsby, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Kat Abtahi", 
                    "phone": "925-478-5488"
                }, 
                "facility": {
                    "address": {
                        "city": "Walnut Creek", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "94598"
                    }, 
                    "name": "IPM Medical Group, Inc."
                }, 
                "investigator": {
                    "last_name": "Kasra Amirdelfan, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Susan Clark", 
                    "phone": "321-348-9689"
                }, 
                "facility": {
                    "address": {
                        "city": "Merritt Island", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "32953"
                    }, 
                    "name": "Florida Pain Institute"
                }, 
                "investigator": {
                    "last_name": "Stan Golovac, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Mandy Mead", 
                    "phone": "732-380-0200", 
                    "phone_ext": "27"
                }, 
                "facility": {
                    "address": {
                        "city": "Shrewsbury", 
                        "country": "United States", 
                        "state": "New Jersey", 
                        "zip": "07702"
                    }, 
                    "name": "Premier Pain Center"
                }, 
                "investigator": {
                    "last_name": "Peter Staats, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "hadielnawaz@houstonpain.com", 
                    "last_name": "Hadiel Nawaz", 
                    "phone": "713-973-7246", 
                    "phone_ext": "3526"
                }, 
                "facility": {
                    "address": {
                        "city": "Houston", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "77030"
                    }, 
                    "name": "Houston Pain Centers"
                }, 
                "investigator": {
                    "last_name": "Allen Burton, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Tina Garten", 
                    "phone": "304-347-6144"
                }, 
                "facility": {
                    "address": {
                        "city": "Charleston", 
                        "country": "United States", 
                        "state": "West Virginia", 
                        "zip": "25301"
                    }, 
                    "name": "Center for Pain Relief"
                }, 
                "investigator": {
                    "last_name": "Chris Kim, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "A Prospective, Randomized, Multi-Center, Controlled Clinical Trial to Assess the Safety and Efficacy of the Spinal Modulation\u2122 AXIUM\u2122 Neurostimulator System in the Treatment of Chronic Pain (ACCURATE Trial)", 
        "overall_contact": {
            "email": "linda@spinalmodulation.com", 
            "last_name": "Linda Johnson, PhD", 
            "phone": "650 543 6800"
        }, 
        "overall_contact_backup": {
            "email": "smcquillan@spinalmodulation.com", 
            "last_name": "Steve McQuillan", 
            "phone": "650 543 6800"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Treatment Success is defined as a reduction in pain score greater than or equal to 50 percent and the absence of a stimulation related neurological deficit.", 
            "measure": "Treatment Success", 
            "safety_issue": "Yes", 
            "time_frame": "3 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01923285"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Spinal Modulation, Inc.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Spinal Modulation, Inc.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "August 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "October 2013"
    }
}